# CARISMA THERAPEUTICS INC COM

CARISMA THERAPEUTICS INC COM is a security (CUSIP 14216R101) tracked across SEC portfolio filings. 4 institutional managers reported $48K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $0 via N-PORT as of 2026-05-29.

## Summary

- Issuer: CARISMA THERAPEUTICS INC
- Class: COM
- CUSIP: 14216R101
- Asset category: EC
- 13F holders: 4
- 13F value: $48K
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $0
- N-PORT report: 2026-05-29

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| Merck & Co., Inc. | RAHWAY, NJ | $48K | 1,473,240 |
| [ORG Partners LLC](https://search.stillhousedata.com/firm/312728) | ROANOKE, IN | $8 | 200 |
| Union Bancaire Privee, UBP SA | GENEVA 1, V8 | $4 | 785 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $0 | 0.00% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/14216R101.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.